π End of Day Bhavcopy
Date: 2025-09-09
Price: 69.86
% Change: -1.87% (Prev Close: 71.19)
Volume: 53,893
% Change: -5.11% (Prev Volume: 56,797)
Delivery: 0
Delivery % : 0.00
% Change: 0.00% (Prev Delivery: 0)
Turnover: 38 Lacs
% Change: -4.14% (Prev Turnover: 40)
πΉ EOD Valuation
P/E Ratio: 47.20
P/B Ratio: 1.43
Market Cap: 198 Rs. Cr.
Fundamental Data
Date: 05-09-2025
π·οΈ Company Basics
Symbol: AAREYDRUGS
Market Cap: 171 Rs. Cr.
Face Value: 10.00 Rs.
52 Week High: 75.75
52 Week Low: 31.30
All-Time High: 143.95 Rs.
All-Time Low: 9.02 Rs.
Stock Price Increase (% Return) %
% Return (1 mth |3 mth | 6 mth | 1 Yr | 3 Yrs | 5 Yrs):
-0.56% | 26.15% | 71.48% | -5.42% | 19.64%
π₯ Shareholding Pattern
Promoter Holding
Promoter Holding: 44.80%
Change (3Y | 1Y): -5.23% | 0.00%
Pledged %: 0.00%
FII Holding
FII Holding: 1.97%
Change (3Y | 1Y): -1.95% | -0.37%
DII Holding
DII Holding: 0.00%
Change (3Y | 1Y): 0.00% | 0.00%
Public Holding: 53.23%
π¦ Financial Strength
Debt to Equity: 0.25
Debt: 34.86 Rs. Cr.
Book Value: 48.84 Rs.
Current Ratio: 2.20
Interest Coverage: 2.90
Free Cash Flow: 4.45 Rs. Cr.
π Growth & Sales
Sales Growth: -4.74%
Sales Growth Qtr (YOY | QoQ):
-19.46% | -5.45%
Sales Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
9.76% | -1.29% | -4.74%
π° Profit & Earnings
Profit Growth %
Profit Growth: -26.24%
Profit Growth Qtr (YOY | QoQ):
10.48% | 191.49%
Profit Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
-7.04% | -15.02% | -26.24%
EPS Rs.
EPS (TTM): 1.48 Rs.
EPS Qtr (Last Year | Latest):
0.44 Rs. | 0.48 Rs.
EPS Annual (Last Annual | Annual March):
1.67 Rs. | 1.42 Rs.
EPS Growth Variation % (5 Yrs | 3 Yrs):
-10.55% | -18.09%
Net Profit Rs. Cr.
Net Profit (TTM): 4.16 Rs. Cr.
Net Profit (Annual - March): 4.02 Rs. Cr.
Net Profit Qtr (Last Year Q | Previous Q | Latest Q):
1.24| 0.47 | 1.37
EBITDA Rs. Cr.
EBITDA (Quarter): 3.26 Rs. Cr.
EBITDA (Previous Yr Ql): 2.76 Rs. Cr.
EBITDA (Annual - March): 12.71 Rs. Cr.
EBITDA (Previous Annual): 11.42 Rs. Cr.
EBITDA (5 Yrs | 3 Yrs) %:
5.06% | -3.33%
π Profitability Ratios
Operating Margin (OPM)
OPM (TTM): 0.76%
OPM Qtr (Previous | Current):
-3.89% | 1.67%
OPM Annual (5 Yrs | Last Yr | March):
1.46% | 1.13% | 0.61%
Return on Equity %
ROE: 2.96%
ROE (5 Yrs | 3 Yrs | Last Yr):
4.42% | 3.31% | 3.74%
Return on Capital Employed %
ROCE: 6.38%
ROCE (5 Yrs | 3 Yrs | Last Yr):
7.62% | 6.25% | 6.09%
Return on Assets %
ROA (TTM): 1.48%
ROA (5 Yrs | 3 Yrs | Last Yr):
2.05% | 1.49% | 1.57%
PEG Ratio: -2.73
Dividend Yield: 0.00%
PE 3 Yrs: 26.30
PE 5 Yrs: 20.43
Dividend Yield: 0.00%
π₯ Company
Aarey Drugs & Pharmaceuticals Ltd
AAREYDRUGS
Promoter Holding: %